Biblio

Export 1397 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., “Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., “Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
S. C. C. Chan, Chan, C. C. H., Derbie, A. Y., Hui, I., Tan, D. G. H., Pang, M. Y. C., Lau, S. C. L., and Fong, K. N. K., “Chinese Calligraphy Writing for Augmenting Attentional Control and Working Memory of Older Adults at Risk of Mild Cognitive Impairment: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 58, no. 3, pp. 735-746, 2017.
D. E. Moss, Perez, R. G., and Kobayashi, H., “Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1285-1294, 2017.
V. Vasquez, Mitra, J., Hegde, P. M., Pandey, A., Sengupta, S., Mitra, S., Rao, K. S., and Hegde, M. L., “Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.”, J Alzheimers Dis, 2017.
F. Gelfo, Cutuli, D., Nobili, A., De Bartolo, P., D'Amelio, M., Petrosini, L., and Caltagirone, C., “Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1505-1518, 2017.
L. T. Grinberg, Anghinah, R., Nascimento, C. Fernandes, Amaro, E., Leite, R. P., Martin, Mda Graça, Naslavsky, M. S., Takada, L. T., Filho, W. Jacob, Pasqualucci, C. A., and Nitrini, R., “Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player.”, J Alzheimers Dis, vol. 54, no. 1, pp. 169-74, 2016.
S. Villarreal, Zhao, F., Hyde, L. A., Holder, D., Forest, T., Sondey, M., Chen, X., Sur, C., Parker, E. M., and Kennedy, M. E., “Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1393-1413, 2017.
M. Haddad, Perrotte, M., Landri, S., Lepage, A., Fülöp, T., and Ramassamy, C., “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
P. Piscopo, Grasso, M., Puopolo, M., D'Acunto, E., Talarico, G., Crestini, A., Gasparini, M., Campopiano, R., Gambardella, S., Castellano, A. Elisa, Bruno, G., Denti, M. A., and Confaloni, A., “Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 455-464, 2018.
P. Piscopo, Grasso, M., Puopolo, M., D'Acunto, E., Talarico, G., Crestini, A., Gasparini, M., Campopiano, R., Gambardella, S., Castellano, A. Elisa, Bruno, G., Denti, M. A., and Confaloni, A., “Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 455-464, 2018.
M. C. de Olive Otto, H Y Wu, J., Thacker, E. L., Lai, H. Tsz Mung, Lemaitre, R. N., Padhye, N., Song, X., King, I. B., Lopez, O., Siscovick, D. S., and Mozaffarian, D., “Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults.”, J Alzheimers Dis, vol. 95, no. 3, pp. 965-979, 2023.
P. Gareri, Castagna, A., Cotroneo, A. Maria, Putignano, D., Conforti, R., Santamaria, F., Marino, S., and Putignano, S., “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
P. Gareri, Castagna, A., Cotroneo, A. Maria, Putignano, D., Conforti, R., Santamaria, F., Marino, S., and Putignano, S., “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., “Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
S. M. Rao, Galioto, R., Sokolowski, M., Pierce, M., Penn, L., Sturtevant, A., Skugor, B., Anstead, B., Leverenz, J. B., Schindler, D., Blum, D., Alberts, J. L., and Posk, L., “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
S. M. Rao, Galioto, R., Sokolowski, M., Pierce, M., Penn, L., Sturtevant, A., Skugor, B., Anstead, B., Leverenz, J. B., Schindler, D., Blum, D., Alberts, J. L., and Posk, L., “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
S. M. Rao, Galioto, R., Sokolowski, M., Pierce, M., Penn, L., Sturtevant, A., Skugor, B., Anstead, B., Leverenz, J. B., Schindler, D., Blum, D., Alberts, J. L., and Posk, L., “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
E. Christiane Gertje, Pluta, J., Das, S., Mancuso, L., Kliot, D., Yushkevich, P., and Wolk, D., “Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1027-1037, 2016.
D. Bergeron, Beauregard, J. - M., Guimond, J., Fortin, M. - P., Houde, M., Poulin, S., Verret, L., Bouchard, R. W., and Laforce, R., “Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.”, J Alzheimers Dis, vol. 49, no. 3, pp. 695-705, 2016.
O. N. Groeneveld, Moneti, C., Heinen, R., de Bresser, J., Kuijf, H. J., Exalto, L. G., Boomsma, J. M. F., L Kappelle, J., Barkhof, F., Prins, N. D., Scheltens, P., van der Flier, W. M., and Biessels, G. Jan, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
L. F. J. R. Miranda, Gomes, K. B., Tito, P. A. L., Silveira, J. N., Pianetti, G. A., Byrro, R. M. D., Peles, P. R. H., Pereira, F. H., Santos, T. R., Assini, A. G., Ribeiro, V. V., Moraes, E. N., and Caramelli, P., “Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.”, J Alzheimers Dis, vol. 55, no. 2, pp. 539-549, 2017.
L. F. J. R. Miranda, Gomes, K. B., Tito, P. A. L., Silveira, J. N., Pianetti, G. A., Byrro, R. M. D., Peles, P. R. H., Pereira, F. H., Santos, T. R., Assini, A. G., Ribeiro, V. V., Moraes, E. N., and Caramelli, P., “Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.”, J Alzheimers Dis, vol. 55, no. 2, pp. 539-549, 2017.
L. F. J. R. Miranda, Gomes, K. B., Tito, P. A. L., Silveira, J. N., Pianetti, G. A., Byrro, R. M. D., Peles, P. R. H., Pereira, F. H., Santos, T. R., Assini, A. G., Ribeiro, V. V., Moraes, E. N., and Caramelli, P., “Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.”, J Alzheimers Dis, vol. 55, no. 2, pp. 539-549, 2017.
E. Morenas-Rodriguez, Sala, I., Subirana, A., Pascual-Goñi, E., Sánchez-Saudinós, M. Belén, Alcolea, D., Illán-Gala, I., Carmona-Iragui, M., Ribosa-Nogué, R., Camacho, V., Blesa, R., Fortea, J., and Lleo, A., “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.

Pages